Literature DB >> 30785734

Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213.

Ilia G Denisov, Yelena V Grinkova, Prithviraj Nandigrami, Mrinal Shekhar, Emad Tajkhorshid, Stephen G Sligar.   

Abstract

The role of Phe213 in the allosteric mechanism of human cytochrome P450 CYP3A4 was studied using a combination of progesterone (PGS) and carbamazepine (CBZ) as probe substrates. We expressed, purified, and incorporated into POPC Nanodiscs three mutants, F213A, F213S, and F213Y, and compared them with wild-type (WT) CYP3A4 by monitoring spectral titration, the rate of NADPH oxidation, and steady-state product turnover rates with pure substrates and substrate mixtures. All mutants demonstrated higher activity with CBZ, lower activity with PGS, and a reduced level of activation of CBZ epoxidation by PGS, which was most pronounced in the F213A mutant. Using all-atom molecular dynamics simulations, we compared the dynamics of WT CYP3A4 and the F213A mutant incorporated into the lipid bilayer and the effect of the presence of the PGS molecule at the allosteric peripheral site and evaluated the critical role of Phe213 in mediating the heterotropic allosteric interactions in CYP3A4.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30785734      PMCID: PMC7003538          DOI: 10.1021/acs.biochem.8b01268

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  60 in total

1.  Update of the cholesterol force field parameters in CHARMM.

Authors:  Joseph B Lim; Brent Rogaski; Jeffery B Klauda
Journal:  J Phys Chem B       Date:  2011-12-19       Impact factor: 2.991

2.  Functional reconstitution of monomeric CYP3A4 with multiple cytochrome P450 reductase molecules in Nanodiscs.

Authors:  Yelena V Grinkova; Ilia G Denisov; Stephen G Sligar
Journal:  Biochem Biophys Res Commun       Date:  2010-06-17       Impact factor: 3.575

3.  Structural differences between soluble and membrane bound cytochrome P450s.

Authors:  I G Denisov; A Y Shih; S G Sligar
Journal:  J Inorg Biochem       Date:  2011-12-14       Impact factor: 4.155

Review 4.  Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.

Authors:  W Tang; R A Stearns
Journal:  Curr Drug Metab       Date:  2001-06       Impact factor: 3.731

5.  Peripheral ligand-binding site in cytochrome P450 3A4 located with fluorescence resonance energy transfer (FRET).

Authors:  Dmitri R Davydov; Jessica A O Rumfeldt; Elena V Sineva; Harshica Fernando; Nadezhda Y Davydova; James R Halpert
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

6.  Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity.

Authors:  T L Domanski; Y A He; K K Khan; F Roussel; Q Wang; J R Halpert
Journal:  Biochemistry       Date:  2001-08-28       Impact factor: 3.162

7.  Cooperativity in oxidations catalyzed by cytochrome P450 3A4.

Authors:  Y F Ueng; T Kuwabara; Y J Chun; F P Guengerich
Journal:  Biochemistry       Date:  1997-01-14       Impact factor: 3.162

8.  CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.

Authors:  Ping Kang; Mingxiang Liao; Michael R Wester; J Steven Leeder; Robin E Pearce; Maria Almira Correia
Journal:  Drug Metab Dispos       Date:  2007-12-20       Impact factor: 3.922

9.  Homotropic cooperativity of monomeric cytochrome P450 3A4 in a nanoscale native bilayer environment.

Authors:  Bradley J Baas; Ilia G Denisov; Stephen G Sligar
Journal:  Arch Biochem Biophys       Date:  2004-10-15       Impact factor: 4.013

10.  A large-scale allosteric transition in cytochrome P450 3A4 revealed by luminescence resonance energy transfer (LRET).

Authors:  Elena V Sineva; Jessica A O Rumfeldt; James R Halpert; Dmitri R Davydov
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more
  8 in total

1.  Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4.

Authors:  Ilia G Denisov; Yelena V Grinkova; Mark A McLean; Tyler Camp; Stephen G Sligar
Journal:  Biomolecules       Date:  2022-06-20

2.  Molecular Mechanism for Attractant Signaling to DHMA by E. coli Tsr.

Authors:  Asuka A Orr; Jingyun Yang; Nitesh Sule; Ravi Chawla; Kenneth G Hull; Mingzhao Zhu; Daniel Romo; Pushkar P Lele; Arul Jayaraman; Michael D Manson; Phanourios Tamamis
Journal:  Biophys J       Date:  2019-11-27       Impact factor: 4.033

3.  Homotropic Cooperativity of Midazolam Metabolism by Cytochrome P450 3A4: Insight from Computational Studies.

Authors:  Junhao Li; Yue Chen; Yun Tang; Weihua Li; Yaoquan Tu
Journal:  J Chem Inf Model       Date:  2021-04-22       Impact factor: 4.956

4.  Midazolam as a Probe for Drug-Drug Interactions Mediated by CYP3A4: Homotropic Allosteric Mechanism of Site-Specific Hydroxylation.

Authors:  Ilia G Denisov; Yelena V Grinkova; Tyler Camp; Mark A McLean; Stephen G Sligar
Journal:  Biochemistry       Date:  2021-05-20       Impact factor: 3.321

Review 5.  Nanodiscs: A toolkit for membrane protein science.

Authors:  Stephen G Sligar; Ilia G Denisov
Journal:  Protein Sci       Date:  2020-11-16       Impact factor: 6.993

6.  Effects of alcohol-induced increase in CYP2E1 content in human liver microsomes on the activity and cooperativity of CYP3A4.

Authors:  Bikash Dangi; Nadezhda Y Davydova; Marc A Maldonado; Armina Abbasi; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Arch Biochem Biophys       Date:  2020-11-13       Impact factor: 4.013

7.  Structural Basis for the Diminished Ligand Binding and Catalytic Ability of Human Fetal-Specific CYP3A7.

Authors:  Irina F Sevrioukova
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

8.  In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes.

Authors:  Yang Li; Jing Qin; Hong Wu; Yongmei Xu; Li Zhang; Keren Su; Ying Cui; Haiping Wang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.